NEW YORK (GenomeWeb News) – ChanTest has won a $4.8 million grant from the State of Ohio that it plans to use to expand its G-protein coupled receptor and ion channel products and services, the company said today.

The Cleveland-based company received the competitive grant through Ohio's Third Frontier Research and Commercialization Program

The company plans to use the funds to expand its library of validated ion channel and GPCR cell line products and services, and on its electrogenic transporter and stem-cell derived heart cell services.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The New York Times and ProPublica look into the close relationship between a startup and Memorial Sloan Kettering Cancer Center.

Yahoo News reports millions of dollars are being transferred from NIH, CDC, and other programs to pay for the housing of detained undocumented immigrant children.

Researchers gave a handful of octopuses MDMA to find that they too act more social on the drug, Gizmodo reports.

In Science this week: in vitro generation of human reproductive cells, and more.